Company filings profile · CIK 0001743881
BridgeBio Pharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for BridgeBio Pharma, Inc. (BBIO): 21 filings in the last 90 days vs 49 in the prior 90 (filing-velocity cooling ↓ · 0.43×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 13, 2026. Source-linked, daily-refreshed.
Material 8-K events — BridgeBio Pharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 13, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 17, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 10, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 22, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
Watch BridgeBio Pharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 13, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 21, 2026 | 4 | FORM 4 | ↗ |
| Aug 31, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 20, 2026 | 4 | FORM 4 | ↗ |
| Aug 19, 2026 | 144 | ↗ | |
| Aug 18, 2026 | 4 | FORM 4 | ↗ |
| Aug 18, 2026 | 4 | FORM 4 | ↗ |
| Aug 18, 2026 | 4 | FORM 4 | ↗ |
| Aug 18, 2026 | 144 | ↗ | |
| Aug 17, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 17, 2026 | 144 | ↗ | |
| Aug 17, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 424B7 | 424B7 | ↗ |
| Aug 10, 2026 | 10-Q | 10-Q | ↗ |
| Aug 10, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | 4 | FORM 4 | ↗ |
| Aug 3, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 27, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 24, 2026 | S-3ASR | S-3ASR | ↗ |
| Jul 24, 2026 | S-8 | S-8 | ↗ |
| Jul 22, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 13, 2026 | 4 | FORM 4 | ↗ |
| Jul 13, 2026 | 4 | FORM 4 | ↗ |
| Jul 10, 2026 | SCHEDULE 13D/A | ↗ | |
| Jul 9, 2026 | 144 | ↗ | |
| Jul 9, 2026 | 144 | ↗ | |
| Jul 2, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Item 3.03; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |
| Jun 24, 2026 | 4 | FORM 4 | ↗ |